Mahaney Paige bought CCCC
February 14, 2025 · Form 4 insider transaction
Mahaney Paige bought 28,200 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,200
Price
$0.00
Total value
N/A
InsiderMahaney Paige
RoleOfficer
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2025
Filing dateFebruary 18, 2025
Shares owned after105,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.